Macrophage migration inhibitory factor (MIF), is a pro-inflammatory cytokine produced by the urothelium. During bladder inflammation, MIF production is upregulated in the bladder and MIF is released into the intraluminal space where it exerts proinflammatory effects on the urothelium by activating downstream inflammatory mediators. A novel finding is that MIF is released, not as an unbound momeric protein, but in high-molecular weight complexes with alpha-1 inhibitor 3, a protease inhibitor in the family of alpha2- macroglobulins. In addition, in another novel finding, MIF-alpha1 inhibitor 3 complexes associate with surface glucose related protein 78 in the bladder which likely results in activation of signal transduction pathways. The overall goal of the present proposal is to continue to investigate the mechanism of MIF- mediated inflammation in the bladder by investigating these two novel findings. Based on our recent experimental evidence, our working hypothesis is that during neurogenic inflammation, MIF is released into the bladder lumen and interacts with specific cell-surface proteins (either CD74 or glucose regulated protein 78) on the urothelium to activate signal transduction pathways resulting in the production of other pro- inflammatory mediators. Thus, even though the effects of tachykinins (e.g. Substance P; SP) on the bladder are short-lived, activation of MIF results in an inflammatory loop that, if left unchecked, regulates other inflammatory mediators and maintains an inflammatory condition. In the new line of research described in the present proposal, we will examine in greater detail the mechanisms of MIF release, the effects of blockade of specific cell-surface molecules associated with MIF in the urothelium and the ability of MIF complexes to activate signal transduction in well-described in vitro systems. Identification of the effect of novel cell-surface proteins associated with MIF will add to knowledge of basic mechanisms of MIF's pro- inflammatory functions, and thus the findings of this proposal may extend to other inflammatory conditions where MIF has been demonstrated to play a role. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21DK075059-01A1
Application #
7147846
Study Section
Urologic and Kidney Development and Genitourinary Diseases Study Section (UKGD)
Program Officer
Mullins, Christopher V
Project Start
2006-09-30
Project End
2008-08-31
Budget Start
2006-09-30
Budget End
2007-08-31
Support Year
1
Fiscal Year
2006
Total Cost
$176,335
Indirect Cost
Name
Bay Pines Foundation, Inc.
Department
Type
DUNS #
055854074
City
Bay Pines
State
FL
Country
United States
Zip Code
33744
Young, LeAnne H; Periwal, Vipul (2016) Metabolic scaling predicts posthepatectomy liver regeneration after accounting for hepatocyte hypertrophy. Liver Transpl 22:476-84
Meyer-Siegler, Katherine L; Cox, Jacob; Leng, Lin et al. (2010) Macrophage migration inhibitory factor anti-thrombin III complexes are decreased in bladder cancer patient serum: Complex formation as a mechanism of inactivation. Cancer Lett 290:49-57
Vera, Pedro L; Iczkowski, Kenneth A; Howard, Daniel J et al. (2010) Antagonism of macrophage migration inhibitory factor decreases cyclophosphamide cystitis in mice. Neurourol Urodyn 29:1451-7
Vera, Pedro L; Wolfe, Terra E; Braley, Alexander E et al. (2010) Thrombin induces macrophage migration inhibitory factor release and upregulation in urothelium: a possible contribution to bladder inflammation. PLoS One 5:e15904
Vera, Pedro L; Wang, Xihai; Bucala, Richard J et al. (2009) Intraluminal blockade of cell-surface CD74 and glucose regulated protein 78 prevents substance P-induced bladder inflammatory changes in the rat. PLoS ONE 4:e5835
Meyer-Siegler, Katherine L; Xia, Shen-Ling; Vera, Pedro L (2009) Substance P increases cell-surface expression of CD74 (receptor for macrophage migration inhibitory factor): in vivo biotinylation of urothelial cell-surface proteins. Mediators Inflamm 2009:535348
Vera, Pedro L; Iczkowski, Kenneth A; Wang, Xihai et al. (2008) Cyclophosphamide-induced cystitis increases bladder CXCR4 expression and CXCR4-macrophage migration inhibitory factor association. PLoS One 3:e3898
Vera, Pedro L; Wang, Xihai; Meyer-Siegler, Katherine L (2008) Neural control of substance P induced up-regulation and release of macrophage migration inhibitory factor in the rat bladder. J Urol 180:373-8
Vera, Pedro L; Wang, Xihai; Meyer-Siegler, Katherine L (2008) Upregulation of macrophage migration inhibitory factor (MIF) and CD74, receptor for MIF, in rat bladder during persistent cyclophosphamide-induced inflammation. Exp Biol Med (Maywood) 233:620-6
Meyer-Siegler, K L; Vera, P L; Iczkowski, K A et al. (2007) Macrophage migration inhibitory factor (MIF) gene polymorphisms are associated with increased prostate cancer incidence. Genes Immun 8:646-52